170 related articles for article (PubMed ID: 20155331)
1. In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissue.
Torres SM; Divi RL; Walker DM; McCash CL; Carter MM; Campen MJ; Einem TL; Chu Y; Seilkop SK; Kang H; Poirier MC; Walker VE
Cardiovasc Toxicol; 2010 Jun; 10(2):87-99. PubMed ID: 20155331
[TBL] [Abstract][Full Text] [Related]
2. In utero exposure of female CD-1 Mice to AZT and/or 3TC: I. Persistence of microscopic lesions in cardiac tissue.
Torres SM; March TH; Carter MM; McCash CL; Seilkop SK; Poirier MC; Walker DM; Walker VE
Cardiovasc Toxicol; 2010 Mar; 10(1):37-50. PubMed ID: 20101476
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial compromise in 3-year old patas monkeys exposed in utero to human-equivalent antiretroviral therapies.
Liu Y; Shim Park E; Gibbons AT; Shide ED; Divi RL; Woodward RA; Poirier MC
Environ Mol Mutagen; 2016 Aug; 57(7):526-34. PubMed ID: 27452341
[TBL] [Abstract][Full Text] [Related]
5. Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3'-azido-3'-deoxythymidine.
Walker DM; Poirier MC; Campen MJ; Cook DL; Divi RL; Nagashima K; Lund AK; Cossey PY; Hahn FF; Walker VE
Cardiovasc Toxicol; 2004; 4(2):133-53. PubMed ID: 15371630
[TBL] [Abstract][Full Text] [Related]
6. Toxicology and Carcinogenesis Studies of Mixtures of 3'-Azido-3'-Deoxythymidine (AZT), Lamivudine (3TC), and Nevirapine (NVP) (CAS Nos. 30516-87-1, 134678-17-4, 129618-40-2) in Genetically Modified C3B6.129F1-Trp53(tm1Brd) N12 Haploinsufficient Mice (in utero and postnatal gavage studies).
National Toxicology Program
Natl Toxicol Program Genet Modif Model Rep; 2013 Oct; (16):1-236. PubMed ID: 24503698
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations.
Torres SM; Walker DM; Carter MM; Cook DL; McCash CL; Cordova EM; Olivero OA; Poirier MC; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):224-38. PubMed ID: 17358033
[TBL] [Abstract][Full Text] [Related]
8. Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).
Divi RL; Einem TL; Fletcher SL; Shockley ME; Kuo MM; St Claire MC; Cook A; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC
Toxicol Sci; 2010 Nov; 118(1):191-201. PubMed ID: 20702595
[TBL] [Abstract][Full Text] [Related]
9. Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age.
Divi RL; Leonard SL; Walker BL; Kuo MM; Shockley ME; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC
Toxicol Sci; 2007 Sep; 99(1):203-13. PubMed ID: 17545213
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine.
Gerschenson M; Nguyen V; Ewings EL; Ceresa A; Shaw JA; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Olivero OA; Divi RL; Albert PS; Poirier MC
AIDS Res Hum Retroviruses; 2004 Jan; 20(1):91-100. PubMed ID: 15000702
[TBL] [Abstract][Full Text] [Related]
11. Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors.
Divi RL; Leonard SL; Kuo MM; Walker BL; Orozco CC; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Thamire C; Sable CA; Poirier MC
Cardiovasc Toxicol; 2005; 5(3):333-46. PubMed ID: 16244378
[TBL] [Abstract][Full Text] [Related]
12. Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylation.
Kohler JJ; Hosseini SH; Cucoranu I; Hoying-Brandt A; Green E; Johnson D; Wittich B; Srivastava J; Ivey K; Fields E; Russ R; Raper CM; Santoianni R; Lewis W
Lab Invest; 2009 Feb; 89(2):122-30. PubMed ID: 19079325
[TBL] [Abstract][Full Text] [Related]
13. Toxicology and carcinogenesis studies of mixtures of 3'-azido-3'-deoxythymidine (AZT), lamivudine (3TC), nevirapine (NVP), and nelfinavir mesylate (NFV) (Cas Nos. 30516-87-1, 134678-17-4, 129618-40-2, 159989-65-8) in B6C3F1 Mice (transplacental exposure studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2013 Jan; (569):1-212. PubMed ID: 23385634
[TBL] [Abstract][Full Text] [Related]
14. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
[TBL] [Abstract][Full Text] [Related]
15. Prenatal AZT or 3TC and mouse development of locomotor activity and hot-plate responding upon administration of the GABA(A) receptor agonist muscimol.
Ricceri L; Venerosi A; Valanzano A; Sorace A; Alleva E
Psychopharmacology (Berl); 2001 Feb; 153(4):434-42. PubMed ID: 11243490
[TBL] [Abstract][Full Text] [Related]
16. Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure.
Gerschenson M; Poirier MC
Ann N Y Acad Sci; 2000 Nov; 918():269-81. PubMed ID: 11131713
[TBL] [Abstract][Full Text] [Related]
17. Frequency of Hprt mutant lymphocytes and micronucleated erythrocytes in p53-haplodeficient mice treated perinatally with AZT and AZT in combination with 3TC.
Dobrovolsky VN; Shaddock JG; Mittelstaedt RA; Bishop ME; Lewis SM; Lee FW; Aidoo A; Leakey JE; Dunnick JK; Heflich RH
Environ Mol Mutagen; 2007; 48(3-4):270-82. PubMed ID: 17358030
[TBL] [Abstract][Full Text] [Related]
18. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
Von Tungeln LS; Williams LD; Doerge DR; Shaddock JG; McGarrity LJ; Morris SM; Mittelstaedt RA; Heflich RH; Beland FA
Environ Mol Mutagen; 2007; 48(3-4):258-69. PubMed ID: 16850453
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
Olivero OA; Tejera AM; Fernandez JJ; Taylor BJ; Das S; Divi RL; Poirier MC
Mutagenesis; 2005 Mar; 20(2):139-46. PubMed ID: 15784690
[TBL] [Abstract][Full Text] [Related]
20. Genotoxic and functional consequences of transplacental zidovudine exposure in fetal monkey brain mitochondria.
Ewings EL; Gerschenson M; St Claire MC; Nagashima K; Skopets B; Harbaugh SW; Harbaugh JW; Poirier MC
J Acquir Immune Defic Syndr; 2000 Jun; 24(2):100-5. PubMed ID: 10935684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
